AGEs (Advanced Glycation End-products) in bone come of age
Deepak Vashishth1, Ruban Dhaliwal2, Mishaela Rubin3
1Shirley Ann Jackson PhD. Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY, United States of America; Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, NY, United States of America; Rensselaer - Icahn School of Medicine at Mount Sinai Center for Engineering and Precision Medicine, New York, NY, United States of America.
None:
Advanced Glycation End-products (AGEs) are seen in long-lived proteins and were not expected to accumulate in the bone that turnovers and renews itself. Here, we provide a commentary on the contrary, highlighting the Special Issue of AGEs in Bone. An outcome of hyperglycemia and increased oxidative stress, AGEs form and accumulate by altering the bone resorption and formation processes. Accumulation of various AGEs species in bone increases bone fragility through the stiffening of the collagen network and, potentially, through the changes in collagen-mineral interactions. Evidence from both preclinical and clinical studies is leading to new translational approaches wherein measurement, inhibition, or removal of AGEs show the potential to diagnose, manage, and treat bone fragility associated with multiple conditions and diseases.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Proteoglycans


